Is there an association between inflammatory/anti-oxidant markers and the presence of psychotic symptoms or severity of illness in mood and psychotic disorders? A multi-centric study on a drug-free sample.
Inflammation
Mood disorders
Oxidative stress
Psychotic disorders
Vitamins
Journal
Brain, behavior, & immunity - health
ISSN: 2666-3546
Titre abrégé: Brain Behav Immun Health
Pays: United States
ID NLM: 101759062
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
received:
06
02
2021
revised:
08
03
2022
accepted:
12
03
2022
entrez:
11
4
2022
pubmed:
12
4
2022
medline:
12
4
2022
Statut:
epublish
Résumé
The immune and antioxidant systems are intimately connected and their role in the etiology of major psychiatric disorders is currently under study. The aim of this study was to evaluate the potential associations between inflammatory/antioxidant peripheral markers and presence of psychotic symptoms or severity of illness in patients affected by major psychiatric disorders. One hundred and twenty-six drug-free patients were included. A blood sample was collected to measure total/B/T lymphocytes and plasma levels of albumin, total bilirubin, uric acid, C-reactive protein, and vitamins A and E. Severity of illness was assessed using psychometric scales. Groups of patients divided according to diagnosis were compared in terms of measured markers using multivariate analyses of variance (MANOVAs). Linear and logistic regression analyses were performed to investigate the potential association between markers and severity of illness or presence/absence of psychotic symptoms. Albumin plasma levels were higher in patients with substance-induced psychotic disorder (SIPD) than subjects affected by schizophrenia (F = 4.923; p = 0.003). Lower vitamin E (OR = 0.81; p = 0.014) and T lymphocyte (OR = 0.99; p = 0.048) plasma levels were predictive of lifetime psychotic symptoms. Lower vitamin A levels were associated with higher Montgomery-Åsberg Depression Rating Scale scores (β = -24.26; p = 0.029), independent of diagnosis. Patients with SIPD may be less vulnerable to oxidative stress. The severity of depressive symptoms, inversely associated with vitamin A plasma levels, is likely to be modulated by the degree of inflammation. Patients presenting with lifetime psychotic symptoms may be more vulnerable to oxidative stress and may have a higher activation of humoral immunity.
Identifiants
pubmed: 35403068
doi: 10.1016/j.bbih.2022.100453
pii: S2666-3546(22)00043-6
pmc: PMC8990055
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100453Informations de copyright
© 2022 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Clin Neuropharmacol. 2015 Mar-Apr;38(2):63-4
pubmed: 25768856
Chang Gung Med J. 2002 Aug;25(8):509-13
pubmed: 12392362
Curr Neuropharmacol. 2018;16(5):583-606
pubmed: 29357805
Ned Tijdschr Geneeskd. 2017;161:D1645
pubmed: 29145902
Antioxidants (Basel). 2021 Mar 04;10(3):
pubmed: 33806320
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
Psychiatry Clin Neurosci. 2014 Jan;68(1):21-36
pubmed: 24102953
Psychiatry Clin Neurosci. 2016 Jun;70(6):227-44
pubmed: 26969211
BMC Psychiatry. 2020 Jun 24;20(1):333
pubmed: 32580709
Addict Behav. 2006 Jul;31(7):1245-51
pubmed: 16137832
J Nerv Ment Dis. 2009 Jan;197(1):35-40
pubmed: 19155808
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):664-75
pubmed: 20599581
Pharmazie. 2020 Jan 2;75(1):32-35
pubmed: 32033631
Biol Psychiatry. 2014 Feb 15;75(4):324-31
pubmed: 24286760
Aust N Z J Psychiatry. 2019 Aug;53(8):772-781
pubmed: 30658550
Psychol Med. 2018 Jan;48(1):43-49
pubmed: 28967348
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:200-6
pubmed: 23470289
Psychiatry Res. 2007 Aug 30;152(2-3):173-80
pubmed: 17448544
Schizophr Bull. 2020 Feb 26;46(2):363-373
pubmed: 31504969
Biomed Res Int. 2013;2013:484613
pubmed: 24455696
Schizophr Res. 2003 Aug 1;62(3):205-12
pubmed: 12837516
Psychol Med. 2018 Apr;48(6):905-918
pubmed: 28893329
Schizophr Res. 2018 May;195:32-50
pubmed: 28947341
PLoS One. 2015 Oct 07;10(10):e0138904
pubmed: 26445247
Acta Psychiatr Scand. 2019 Oct;140(4):382-384
pubmed: 31400146
Acta Neuropsychiatr. 2019 Aug;31(4):202-212
pubmed: 31178002
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Aug 30;86:89-94
pubmed: 29778547
Ann N Y Acad Sci. 2019 Feb;1437(1):57-67
pubmed: 29752710
Neurosci Biobehav Rev. 2011 Jan;35(3):878-93
pubmed: 20974172
Antioxidants (Basel). 2019 Dec 25;9(1):
pubmed: 31881765
Int J Bipolar Disord. 2017 Dec;5(1):24
pubmed: 28480482
J Affect Disord. 2018 Jul;234:351-357
pubmed: 29128257
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
pubmed: 14399272
Mol Psychiatry. 2019 Jun;24(6):869-887
pubmed: 30116031
Eur Arch Psychiatry Clin Neurosci. 2010 Oct;260(7):509-18
pubmed: 20107825
BMC Psychiatry. 2020 May 15;20(1):241
pubmed: 32414343
Nitric Oxide. 2019 Oct 1;91:67-76
pubmed: 31323278
Antioxid Redox Signal. 2011 Oct 1;15(7):2011-35
pubmed: 21126177
Am J Psychiatry. 2019 Sep 1;176(9):683-684
pubmed: 31474121
Adv Nutr. 2017 Mar 15;8(2):197-212
pubmed: 28298266
Neurosci Biobehav Rev. 2020 May;112:376-391
pubmed: 32070693